15% OFF YOUR FIRST ORDER · CODE 1stOrder
Research hub

Bronchogen Peptide

Bronchogen Peptide is a synthetic tetrapeptide investigated in laboratory research. Published studies have examined its biological activity in cellular and molecular systems. Direct SARMs United States supplies Bronchogen exclusively for laboratory research. Browse the available research material below.

BronchogenBronchogen PeptideAEDL PeptideBronchogen (Khavinson Peptide)
Molecular Weight
446.45 g/mol
Molecular Formula
C18H30N4O9
Purity
99.5%
Available nowBronchogen Peptide · in stock, EU dispatch
Bronchogen Peptide Vial
20mg
Price range: $51.88 through $63.10View
01

What Is Bronchogen Peptide?

Bronchogen peptide is a synthetic tetrapeptide composed of four amino acid residues. PubChem identifies its sequence as Ala-Glu-Asp-Leu (AEDL).

Bronchogen is a short peptide with four linked amino acid residues: alanine, glutamic acid, aspartic acid, and leucine.

02

Research Overview Table

Research OverviewCurrent Status
Primary Research FieldBronchial epithelial biology and peptide biology
Published Cell StudiesAvailable
Published Animal StudiesAvailable
Controlled Human Clinical TrialsNo controlled human clinical trials identified
Research MaturityPredominantly preclinical
Evidence BaseCell-based, molecular, tissue-culture, and animal studies
Regulatory StatusExperimental research compound
Intended UseLaboratory research only
03

Chemical and Molecular Characteristics

Chemical NameL-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-L-leucine
Compound NameBronchogen
Compound TypeSynthetic tetrapeptide
Molecular FormulaC18H30N4O9
Molecular Weight446.45 g/mol
Purity99.5% by HPLC
Batch/Lot NumberP260702-LR1027056
Primary Research TargetDNA
Product FormatVial
Physical PresentationWhite or almost white powder

Certificates:

CoAhttps://united-states.direct-sarms.com/wp-content/uploads/2026/09/Bronchogen_COA.pdf
HPLChttps://united-states.direct-sarms.com/wp-content/uploads/2026/09/Bronchogen_HPLC.pdf
04

Mechanism of Action Under Investigation

Bronchogen has been investigated for its interaction with DNA. Published research reports binding between Bronchogen and DNA, including interaction with deoxyribooligonucleotides containing different nucleotide sequences. One study found preferential binding to sequences containing CTG, while another reported interaction with both DNA strands, mainly through the nitrogenous bases.

Research has also shown that Bronchogen can alter DNA thermal stability. In one study the peptide increased DNA melting temperature by 3.1°C within a defined peptide-to-DNA ratio range. The reported interaction was considered strong but nonspecific. Published research does not establish a receptor, enzyme target, or defined downstream signaling pathway for Bronchogen.

05

Scientific Research Context

Bronchogen has a relatively small published literature. Available evidence includes cellular, molecular, tissue-culture, and animal studies, with most research remaining preclinical. The literature has progressed from basic laboratory investigations to broader experimental research, but human clinical research has not become an established part of the evidence base. Overall, Bronchogen remains an early-stage research compound.

06

Bronchogen Biology and Biological Pathways

01

Primary Biological Function

Researchers have studied Bronchogen mainly in relation to bronchial epithelial cell differentiation. Published research reports changes in factors and gene expression associated with this process.

02

Relevant Metabolic or Signaling Pathways

Published research has not identified a specific metabolic or signaling pathway for Bronchogen. One study examined genes linked to bronchial epithelial differentiation, including NKX2-1, SCGB1A1, SCGB3A2, FOXA1, FOXA2, MUC4, MUC5AC, and SFTPA1.

03

Tissue-Specific Biology

Bronchogen research is focused on bronchial epithelium and lung tissue. Published studies have examined the bronchial epithelium in human cell cultures and in rat lung tissue. The literature therefore centers on the biology of the bronchial and respiratory tissues rather than a broad range of organs.

04

Experimental Biomarkers

Published Bronchogen research has measured Ki67, Mcl-1, p53, CD79, and NOS-3 at the protein level. Gene-expression analysis has also examined NKX2-1, SCGB1A1, SCGB3A2, FOXA1, FOXA2, MUC4, MUC5AC, and SFTPA1. These markers were used in the published study to assess changes in bronchial epithelial cell biology following exposure to the peptide.

05

Laboratory Investigation Methods

The study measured gene expression with real-time PCR and protein levels for Ki67, Mcl-1, p53, CD79, and NOS-3 in human bronchial epithelial cell cultures. For the DNA interaction, the researchers used spectrophotometry, viscometry and circular dichroism in vitro.

07

Experimental Models Used in Published Research

The published Bronchogen literature includes human bronchial cell cultures, rat models, tobacco callus cultures and cell-free DNA systems. Each model has its own limitations.

01

Human Bronchial Cell Cultures

Cultured human bronchial epithelial cells are one of the experimental models reported for Bronchogen. The limitation is that a cell culture does not reproduce the full structure and complexity of bronchial tissue.

02

Rat Models

The published study used rats with experimentally induced obstructive lung pathology. The limitation is that this induced rat model does not reproduce human respiratory disease in all respects, so its findings cannot directly represent human biology.

03

Tobacco Callus Cultures

Tobacco (Nicotiana tabacum) callus cultures provide a plant-based experimental system in which Bronchogen has been studied. Because plant cells differ substantially from mammalian cells, this model has limited relevance to human biology.

04

Cell-Free DNA Systems

Isolated DNA and deoxyribooligonucleotides served as the in-vitro models in Bronchogen research. The limitation is that these isolated systems do not reproduce the cellular environment present in living cells.

08

Published Scientific Research

01

Bronchial Epithelial Differentiation

Bronchogen has been studied in connection with bronchial epithelial differentiation. One study examined CXCL12 and Hoxa3. While later research examined NKX2-1, SCGB1A1, SCGB3A2, FOXA1, FOXA2, MUC4, MUC5AC, and SFTPA1 in relation to epithelial differentiation.

02

Bronchial Epithelial Cell Proliferation

Bronchogen research has examined cell proliferation and related protein expression in bronchial epithelium. The study measured Ki67, Mcl-1, p53, CD79 and NOS-3 and also examined genes involved in epithelial differentiation.

03

DNA Interaction

Bronchogen has been studied for its interaction with DNA. Published research examined its binding to DNA and deoxyribooligonucleotides, along with changes in DNA thermal stability.

04

Bronchial and Lung Tissue

Published research has investigated Bronchogen in relation to the bronchial epithelium and lung tissue, including changes associated with experimental obstructive lung pathology and inflammatory activity in the lungs.

05

Plant Growth and Differentiation

The study investigated plant growth, development, and differentiation. It also examined the expression of CLE, KNOX1, and GRF gene families and their role in regulating tissue formation, cell differentiation, and growth.

09

Limitations of Current Research

01

Evidence Is Predominantly Preclinical

Bronchogen research remains largely preclinical. The published record centers on laboratory investigations and animal studies, rather than clinical research. This limits the strength of the evidence and makes it difficult to draw conclusions beyond the experimental settings examined.

02

Human Clinical Evidence

Clinical evidence in human participants is limited. Researchers have studied human bronchial cells, but cell-culture findings do not replace clinical research. Without controlled human studies, the literature cannot establish whether observations reported in experimental research have clinical relevance.

03

Species Differences

Species differences create another limitation. Results from rat studies or plant research may not reflect human biology in the same way. Differences in cellular processes and tissue responses can affect how findings translate across species.

04

Study Design Limitations

The published studies examine different aspects of Bronchogen biology, using different experimental approaches and research questions. That variation makes direct comparison difficult. The literature therefore does not provide one consistent experimental framework from which broad conclusions can be drawn.

05

Independent Replication

Independent replication is limited in the identified literature. Several research areas appear in only a few publications. Repeated findings from unrelated research groups would provide stronger evidence that reported observations are reproducible rather than specific to one research setting.

06

Long-Term Evidence

Long-term evidence remains limited. The identified studies do not establish the effects of prolonged exposure over extended periods. Shorter laboratory and preclinical investigations cannot answer whether reported observations persist with time, leaving the longer-term evidence base incomplete.

10

Analytical Documentation

HPLC helps establish peptide purity by separating the target compound from related substances and impurities. The chromatographic profile gives researchers a measurable record of sample composition.

LC-MS adds mass information to the separation. Researchers can compare the measured mass with the expected molecular mass, which supports identity testing and characterization.

NMR can add structural information when the peptide and sample quantity make the technique suitable. Researchers may use it alongside chromatography and mass spectrometry for a more complete analytical assessment.

A Certificate of Analysis (CoA) records the tests and specifications associated with a particular batch. Analytical records such as these give laboratory researchers traceable information about the material under study and help verify its identity and quality. Analytical documentation verifies product identity and quality, not biological performance.

11

Storage and Laboratory Handling

Store Bronchogen at 2–8°C, as specified in the supplied product documentation. Keep the material under the stated storage conditions to maintain the documented quality of the laboratory sample. The available documentation does not specify additional storage requirements.

Qualified laboratory personnel should handle the material using appropriate laboratory procedures. Clean handling practices should limit contamination during storage and testing. Keep the sample properly identified and maintain its batch information for laboratory records. Bronchogen is intended for laboratory research use only.

12

Why Researchers Choose Direct SARMs?

Direct SARMs United States is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.

Our European-made products undergo rigorous purity testing, and we provide clear product information for each research material. We also aim to provide dependable shipping and a smooth ordering experience.

Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.

13

Frequently asked questions

Bronchogen is a synthetic tetrapeptide. The 2012 published study identifies its sequence as Ala-Glu-Asp-Leu and examined it in relation to differentiation factors in human bronchial epithelial cell cultures. Other publications have investigated the peptide in DNA-binding and respiratory-tissue research. The literature therefore describes Bronchogen as a short synthetic peptide studied mainly in experimental systems.
14

Why choose us?

Direct SARMs United States is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.

Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.

Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs United States, we aim to make the research supply process simple, clear, and reliable.

Bronchogen Peptide is supplied solely for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or any clinical application. Information provided on this page is for scientific reference only and should be considered alongside the cited primary literature and relevant analytical documentation.
Available now

Bronchogen Peptide from Direct Sarms United States

Bronchogen Peptide Vial
20mg
Price range: $51.88 through $63.10View